Automated And Closed Cell Therapy Processing Systems Global Market Report 2026
상품코드:1939303
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
자동화·폐쇄형 세포치료 처리 시스템 시장 규모는 최근 급속히 확대하고 있습니다. 2025년 15억 3,000만 달러에서 2026년에는 18억 달러로, CAGR 17.6%로 성장이 전망되고 있습니다. 지난 수년간의 성장 요인으로는 수동 세포 처리 방식, 높은 오염 위험, 제한된 워크플로우 자동화, 기존 바이오리액터에 대한 의존도, 재생의료의 보급 지연 등을 꼽을 수 있습니다.
자동화·폐쇄형 세포치료 처리 시스템 시장 규모는 향후 수년간 급성장이 전망됩니다. 2030년에는 33억 4,000만 달러에 달하며, CAGR은 16.7%에 달할 전망입니다. 예측 기간 중의 성장 요인으로는 통합 폐쇄형 시스템 플랫폼의 개발, 로봇 및 마이크로플루이딕스 기술의 발전, 세포 및 유전자 치료 파이프라인의 확대, 규제 준수 기준 강화, 세포치료제 수탁제조기관(cramos) 증가 등이 있습니다. 예측 기간 중 주요 동향으로는 일회용 및 폐쇄형 시스템 채택 증가, 자동화된 세포 치료 워크플로우에 대한 수요 증가, 오염 최소화 및 안전성 향상에 대한 관심, 다단계 세포 처리 플랫폼의 통합, 재생의학 및 종양학 분야에서의 적용 확대 등이 있습니다.
맞춤형 의료에 대한 수요 증가는 향후 수년간 자동화 및 폐쇄형 세포치료 처리 시스템 시장의 성장을 촉진할 것으로 예측됩니다. 맞춤형 의료란 치료 효과를 높이고 부작용을 줄이기 위해 개인의 유전자, 분자, 세포 프로파일에 따라 맞춤형 의료를 제공하는 것을 말합니다. 이러한 수요 증가는 광범위하게 사용되는 약물보다 표적치료제나 근본적인 치료제의 승인을 촉진하는 강화된 규제 프레임워크와 인센티브에 의해 촉진되고 있습니다. 자동화된 폐쇄형 세포치료제 처리 시스템은 제조업체가 엄격한 규제 요건을 준수하는 일관되고 고품질의 환자 맞춤형 세포치료제를 생산할 수 있도록 지원하여 맞춤형 의료를 실현할 수 있도록 돕습니다. 예를 들어 미국 비영리단체인 맞춤형 의료연합(PMC)에 따르면 2025년 5월 기준 FDA는 2024년 18개의 신규 맞춤형 의료 제품을 승인했으며, 이 중 6건이 유전자 및 세포 기반 치료제로 신규 분자 실체의 약 38%를 차지합니다. 이에 따라 맞춤형 의료에 대한 수요 증가가 자동화 및 폐쇄형 세포치료 처리 시스템 시장의 성장을 촉진하고 있습니다.
이 시장의 주요 기업은 세포치료제 제조의 효율성 향상과 품질 유지를 위해 첨단 세포 준비 플랫폼과 같은 기술 혁신에 집중하고 있습니다. 이 플랫폼은 임상 사용 및 추가 분석을 위해 세포를 효율적으로 분리, 처리 및 준비하여 수작업 및 오염 위험을 줄이는 자동화 시스템입니다. 2024년 10월, 중국에 본사를 둔 생명공학 기업 Sino-Biocan Biotechnology Ltd.는 "WUKONG 자동화 및 폐쇄형 통합 세포 처리 시스템"을 발표했습니다. 이 완전 자동화된 폐쇄형 플랫폼은 채혈부터 세포배양, 최종 충전에 이르는 전체 워크플로우를 효율화합니다. 병원, 제약 연구개발팀, 위탁 개발 및 제조 기관(CDMO)을 위해 설계되었으며, 지능형 제어 및 실시간 모니터링을 통해 효율성을 높이고, 오염 위험을 줄이며, GMP 표준을 준수하는 일관성을 제공합니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 용도 산업의 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 시장의 세계 TAM(Total Addressable Market)
제9장 시장 세분화
제10장 지역별·국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 대기업과 혁신적 기업
제38장 세계의 시장 경쟁 벤치마킹과 대시보드
제39장 주요 합병과 인수
제40장 시장의 잠재력이 높은 국가, 부문, 전략
제41장 부록
KSA
영문 목차
영문목차
Automated and closed cell therapy processing systems are integrated platforms designed to carry out multiple steps of cell therapy manufacturing within a sealed, controlled environment. These systems minimize manual handling, reducing contamination risks and ensuring the production of consistent, high-quality cell products. By automating processes such as cell isolation, expansion, and formulation, they enhance efficiency, reproducibility, and compliance with stringent regulatory standards.
The primary components of automated and closed cell therapy processing systems include software, hardware, and consumables. The software consists of specialized programs that control, monitor, and manage the sterile and precise manufacturing of cell-based therapies. These systems leverage technologies such as microfluidics, robotics, bioreactors, single-use technology, and three-dimensional (3D) cell culture. Key workflows include cryopreservation, separation, fill-finish, expansion, apheresis, and more. They are applied across fields such as oncology, regenerative medicine, autoimmune diseases, infectious diseases, and cardiovascular diseases, serving end users including pharmaceutical and biotechnology companies, research institutes, contract manufacturing organizations, and hospitals.
Tariffs are impacting the automated and closed cell therapy processing systems market by increasing the cost of imported hardware components, bioreactors, and single-use consumables. Segments such as robotics, microfluidics devices, and sterile consumables are most impacted, with regions like North America and Asia-Pacific experiencing higher import costs. This has led to elevated production and operational expenses. On the positive side, tariffs have encouraged local manufacturing investments, innovation in domestic solutions, and diversification of the global supply chain to reduce dependency on imports.
The automated and closed cell therapy processing systems market research report is one of a series of new reports from The Business Research Company that provides automated and closed cell therapy processing systems market statistics, including automated and closed cell therapy processing systems industry global market size, regional shares, competitors with a automated and closed cell therapy processing systems market share, detailed automated and closed cell therapy processing systems market segments, market trends and opportunities, and any further data you may need to thrive in the automated and closed cell therapy processing systems industry. This automated and closed cell therapy processing systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The automated and closed cell therapy processing systems market size has grown rapidly in recent years. It will grow from $1.53 billion in 2025 to $1.8 billion in 2026 at a compound annual growth rate (CAGR) of 17.6%. The growth in the historic period can be attributed to manual cell processing methods, high contamination risks, limited workflow automation, reliance on traditional bioreactors, slow adoption of regenerative therapies.
The automated and closed cell therapy processing systems market size is expected to see rapid growth in the next few years. It will grow to $3.34 billion in 2030 at a compound annual growth rate (CAGR) of 16.7%. The growth in the forecast period can be attributed to development of integrated closed-system platforms, advancements in robotics and microfluidics, growth of cell and gene therapy pipelines, rising regulatory compliance standards, increasing contract manufacturing organizations (cramos) for cell therapies. Major trends in the forecast period include increasing adoption of single-use and closed systems, rising demand for automated cell therapy workflows, focus on minimizing contamination and enhancing safety, integration of multi-step cell processing platforms, expansion of regenerative medicine and oncology applications.
The increasing demand for personalized medicine is anticipated to drive the growth of the automated and closed-cell therapy processing systems market in the coming years. Personalized medicine involves medical treatments customized to an individual's genetic, molecular, or cellular profile to enhance effectiveness and reduce adverse effects. This rising demand is fueled by stronger regulatory frameworks and incentives that favor the approval of targeted and curative therapies over broadly used drugs. Automated and closed-cell therapy processing systems facilitate personalized medicine by allowing manufacturers to produce consistent, high-quality, patient-specific cell therapies that comply with stringent regulatory requirements. For example, in May 2025, according to the Personalized Medicine Coalition (PMC), a US-based non-profit organization, the FDA approved 18 new personalized medicines in 2024, including six gene- or cell-based therapies, accounting for approximately 38 percent of all new molecular entities. As a result, the increasing demand for personalized medicine is propelling the growth of the automated and closed-cell therapy processing systems market.
Leading companies in this market are focusing on technological innovations, such as advanced cell preparation platforms, to enhance efficiency and maintain quality in cell therapy manufacturing. These platforms are automated systems designed to isolate, process, and prepare cells efficiently for clinical use or further analysis while reducing manual labor and contamination risks. In October 2024, Sino-Biocan Biotechnology Ltd., a China-based biotech company, launched the WUKONG Automated, Closed, Integrated Cell Processing System. This fully automated, closed platform streamlines the entire workflow from blood collection to cell culture and final filling. It is intended for hospitals, pharmaceutical R&D teams, and contract development and manufacturing organizations, offering improved efficiency, reduced contamination risks, and GMP-grade consistency through intelligent controls and real-time monitoring.
In March 2024, Donaldson Company Inc., a US-based filtration company, acquired Univercells Technologies for $157.28 million (€136 million). This acquisition strengthens Donaldson's capabilities in life sciences by integrating Univercells Technologies' automated and closed biomanufacturing platforms to provide end-to-end solutions for cell and gene therapy production. Univercells Technologies is a Belgium-based provider of automated and closed cell therapy processing systems.
Major companies operating in the automated and closed cell therapy processing systems market are Thermo Fisher Scientific Inc., Fresenius SE & Co. KGaA, Danaher Corporation, Merck KGaA, Parker Hannifin Corp., Corning Incorporated, Kawasaki Heavy Industries Ltd., Dover Corporation, Lonza Group AG, Terumo Corporation, Sartorius AG, Charles River Laboratories International Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., STEMCELL Technologies Inc., Miltenyi Biotec B.V. & Co. KG, Hamilton Company, Repligen Corporation, Cellares Inc., Ori Biotech Ltd., Autolus Therapeutics Plc.
North America was the largest region in the automated and closed cell therapy processing systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated and closed cell therapy processing systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the automated and closed cell therapy processing systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The automated and closed cell therapy processing systems market includes revenues earned by entities by providing services such as cell separation and isolation, quality control integration, genetic modification, and cell activation. The market value includes the value of related goods sold by the service provider or included within the service offering. The automated and closed cell therapy processing systems market also includes sales of control systems, single-use consumables, automated cell washing systems, and closed-system fluid handling components. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Automated And Closed Cell Therapy Processing Systems Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses automated and closed cell therapy processing systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for automated and closed cell therapy processing systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The automated and closed cell therapy processing systems market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Component: Software; Hardware; Consumables
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
4.2.1 Increasing Adoption Of Single-Use And Closed Systems
4.2.2 Rising Demand For Automated Cell Therapy Workflows
4.2.3 Focus On Minimizing Contamination And Enhancing Safety
4.2.4 Integration Of Multi-Step Cell Processing Platforms
4.2.5 Expansion Of Regenerative Medicine And Oncology Applications
5. Automated And Closed Cell Therapy Processing Systems Market Analysis Of End Use Industries
5.1 Pharmaceutical Companies
5.2 Biotechnology Companies
5.3 Research Institutes
5.4 Contract Manufacturing Organizations (Cramos)
5.5 Hospitals
6. Automated And Closed Cell Therapy Processing Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Automated And Closed Cell Therapy Processing Systems Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Automated And Closed Cell Therapy Processing Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Automated And Closed Cell Therapy Processing Systems Market Size, Comparisons And Growth Rate Analysis
7.3. Global Automated And Closed Cell Therapy Processing Systems Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Automated And Closed Cell Therapy Processing Systems Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Automated And Closed Cell Therapy Processing Systems Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Automated And Closed Cell Therapy Processing Systems Market Segmentation
9.1. Global Automated And Closed Cell Therapy Processing Systems Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Software, Hardware, Consumables
9.2. Global Automated And Closed Cell Therapy Processing Systems Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.3. Global Automated And Closed Cell Therapy Processing Systems Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Cryopreservation, Separation, Fill-Finish, Expansion, Apheresis, Other Workflows
9.4. Global Automated And Closed Cell Therapy Processing Systems Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.5. Global Automated And Closed Cell Therapy Processing Systems Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Pharmaceutical Companies, Biotechnology Companies, Research Institutes, Contract Manufacturing Organizations, Hospitals
9.6. Global Automated And Closed Cell Therapy Processing Systems Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Process Control Software, Data Management Software, Quality Monitoring Software, Workflow Automation Software, Integration Software
9.7. Global Automated And Closed Cell Therapy Processing Systems Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.8. Global Automated And Closed Cell Therapy Processing Systems Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Sterile Bags, Culture Media, Reagents And Buffers, Filters And Cartridges, Single-Use Tubing Sets
10. Automated And Closed Cell Therapy Processing Systems Market Regional And Country Analysis
10.1. Global Automated And Closed Cell Therapy Processing Systems Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Automated And Closed Cell Therapy Processing Systems Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific Automated And Closed Cell Therapy Processing Systems Market
11.1. Asia-Pacific Automated And Closed Cell Therapy Processing Systems Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Automated And Closed Cell Therapy Processing Systems Market, Segmentation By Component, Segmentation By Technology, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Automated And Closed Cell Therapy Processing Systems Market
12.1. China Automated And Closed Cell Therapy Processing Systems Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Automated And Closed Cell Therapy Processing Systems Market, Segmentation By Component, Segmentation By Technology, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Automated And Closed Cell Therapy Processing Systems Market
13.1. India Automated And Closed Cell Therapy Processing Systems Market, Segmentation By Component, Segmentation By Technology, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Automated And Closed Cell Therapy Processing Systems Market
14.1. Japan Automated And Closed Cell Therapy Processing Systems Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Automated And Closed Cell Therapy Processing Systems Market, Segmentation By Component, Segmentation By Technology, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Automated And Closed Cell Therapy Processing Systems Market
15.1. Australia Automated And Closed Cell Therapy Processing Systems Market, Segmentation By Component, Segmentation By Technology, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Automated And Closed Cell Therapy Processing Systems Market
16.1. Indonesia Automated And Closed Cell Therapy Processing Systems Market, Segmentation By Component, Segmentation By Technology, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Automated And Closed Cell Therapy Processing Systems Market
17.1. South Korea Automated And Closed Cell Therapy Processing Systems Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Automated And Closed Cell Therapy Processing Systems Market, Segmentation By Component, Segmentation By Technology, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Automated And Closed Cell Therapy Processing Systems Market
18.1. Taiwan Automated And Closed Cell Therapy Processing Systems Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Automated And Closed Cell Therapy Processing Systems Market, Segmentation By Component, Segmentation By Technology, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Automated And Closed Cell Therapy Processing Systems Market
19.1. South East Asia Automated And Closed Cell Therapy Processing Systems Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Automated And Closed Cell Therapy Processing Systems Market, Segmentation By Component, Segmentation By Technology, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Automated And Closed Cell Therapy Processing Systems Market
20.1. Western Europe Automated And Closed Cell Therapy Processing Systems Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Automated And Closed Cell Therapy Processing Systems Market, Segmentation By Component, Segmentation By Technology, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Automated And Closed Cell Therapy Processing Systems Market
21.1. UK Automated And Closed Cell Therapy Processing Systems Market, Segmentation By Component, Segmentation By Technology, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Automated And Closed Cell Therapy Processing Systems Market
22.1. Germany Automated And Closed Cell Therapy Processing Systems Market, Segmentation By Component, Segmentation By Technology, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Automated And Closed Cell Therapy Processing Systems Market
23.1. France Automated And Closed Cell Therapy Processing Systems Market, Segmentation By Component, Segmentation By Technology, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Automated And Closed Cell Therapy Processing Systems Market
24.1. Italy Automated And Closed Cell Therapy Processing Systems Market, Segmentation By Component, Segmentation By Technology, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Automated And Closed Cell Therapy Processing Systems Market
25.1. Spain Automated And Closed Cell Therapy Processing Systems Market, Segmentation By Component, Segmentation By Technology, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Automated And Closed Cell Therapy Processing Systems Market
26.1. Eastern Europe Automated And Closed Cell Therapy Processing Systems Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Automated And Closed Cell Therapy Processing Systems Market, Segmentation By Component, Segmentation By Technology, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Automated And Closed Cell Therapy Processing Systems Market
27.1. Russia Automated And Closed Cell Therapy Processing Systems Market, Segmentation By Component, Segmentation By Technology, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Automated And Closed Cell Therapy Processing Systems Market
28.1. North America Automated And Closed Cell Therapy Processing Systems Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Automated And Closed Cell Therapy Processing Systems Market, Segmentation By Component, Segmentation By Technology, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Automated And Closed Cell Therapy Processing Systems Market
29.1. USA Automated And Closed Cell Therapy Processing Systems Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Automated And Closed Cell Therapy Processing Systems Market, Segmentation By Component, Segmentation By Technology, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Automated And Closed Cell Therapy Processing Systems Market
30.1. Canada Automated And Closed Cell Therapy Processing Systems Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Automated And Closed Cell Therapy Processing Systems Market, Segmentation By Component, Segmentation By Technology, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Automated And Closed Cell Therapy Processing Systems Market
31.1. South America Automated And Closed Cell Therapy Processing Systems Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Automated And Closed Cell Therapy Processing Systems Market, Segmentation By Component, Segmentation By Technology, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Automated And Closed Cell Therapy Processing Systems Market
32.1. Brazil Automated And Closed Cell Therapy Processing Systems Market, Segmentation By Component, Segmentation By Technology, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Automated And Closed Cell Therapy Processing Systems Market
33.1. Middle East Automated And Closed Cell Therapy Processing Systems Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Automated And Closed Cell Therapy Processing Systems Market, Segmentation By Component, Segmentation By Technology, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Automated And Closed Cell Therapy Processing Systems Market
34.1. Africa Automated And Closed Cell Therapy Processing Systems Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Automated And Closed Cell Therapy Processing Systems Market, Segmentation By Component, Segmentation By Technology, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Automated And Closed Cell Therapy Processing Systems Market Regulatory and Investment Landscape
36. Automated And Closed Cell Therapy Processing Systems Market Competitive Landscape And Company Profiles
36.1. Automated And Closed Cell Therapy Processing Systems Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Automated And Closed Cell Therapy Processing Systems Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Automated And Closed Cell Therapy Processing Systems Market Company Profiles
36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Fresenius SE & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
36.3.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Parker Hannifin Corp. Overview, Products and Services, Strategy and Financial Analysis
37. Automated And Closed Cell Therapy Processing Systems Market Other Major And Innovative Companies
Corning Incorporated, Kawasaki Heavy Industries Ltd., Dover Corporation, Lonza Group AG, Terumo Corporation, Sartorius AG, Charles River Laboratories International Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., STEMCELL Technologies Inc., Miltenyi Biotec B.V. & Co. KG, Hamilton Company, Repligen Corporation, Cellares Inc., Ori Biotech Ltd.
38. Global Automated And Closed Cell Therapy Processing Systems Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The Automated And Closed Cell Therapy Processing Systems Market
40. Automated And Closed Cell Therapy Processing Systems Market High Potential Countries, Segments and Strategies
40.1 Automated And Closed Cell Therapy Processing Systems Market In 2030 - Countries Offering Most New Opportunities
40.2 Automated And Closed Cell Therapy Processing Systems Market In 2030 - Segments Offering Most New Opportunities
40.3 Automated And Closed Cell Therapy Processing Systems Market In 2030 - Growth Strategies
